PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2019 • Market size and forecast 2019-2024 • Market outlook PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Reagents - Market size and forecast 2019-2024 • Equipment - Market size and forecast 2019-2024 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2019-2024 • Europe - Market size and forecast 2019-2024 • Asia - Market size and forecast 2019-2024 • ROW - Market size and forecast 2019-2024 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Rise in clinical trials in developing nations • Geopolitical uncertainties • Rising healthcare expenditures PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Agilent Technologies Inc. • Bio-Rad Laboratories Inc. • F. Hoffmann-La Roche Ltd. • Lonza Group Ltd. • MaxCyte Inc. • Merck KGaA • Polyplus-transfection SA • Promega Corp. • QIAGEN NV • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global healthcare equipment market Exhibit 02: Segments of global healthcare equipment market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Vendor key offerings Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: Product - Market share 2019-2024 (%) Exhibit 19: Comparison by product Exhibit 20: Reagents - Market size and forecast 2019-2024 ($ millions) Exhibit 21: Reagents - Year-over-year growth 2020-2024 (%) Exhibit 22: Equipment - Market size and forecast 2019-2024 ($ millions) Exhibit 23: Equipment - Year-over-year growth 2020-2024 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2019-2024 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions) Exhibit 29: North America - Year-over-year growth 2020-2024 (%) Exhibit 30: Top 3 countries in North America Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions) Exhibit 32: Europe - Year-over-year growth 2020-2024 (%) Exhibit 33: Top 3 countries in Europe Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions) Exhibit 35: Asia - Year-over-year growth 2020-2024 (%) Exhibit 36: Top 3 countries in Asia Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions) Exhibit 38: ROW - Year-over-year growth 2020-2024 (%) Exhibit 39: Top 3 countries in ROW Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Impact of drivers and challenges Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Agilent Technologies Inc. - Vendor overview Exhibit 49: Agilent Technologies Inc. - Business segments Exhibit 50: Agilent Technologies Inc. - Organizational developments Exhibit 51: Agilent Technologies Inc. - Geographic focus Exhibit 52: Agilent Technologies Inc. - Segment focus Exhibit 53: Agilent Technologies Inc. - Key offerings Exhibit 54: Agilent Technologies Inc. - Key customers Exhibit 55: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 56: Bio-Rad Laboratories Inc. - Product segments Exhibit 57: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 58: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 59: Bio-Rad Laboratories Inc. - Segment focus Exhibit 60: Bio-Rad Laboratories Inc. - Key offerings Exhibit 61: Bio-Rad Laboratories Inc. - Key customers Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 68: F. Hoffmann-La Roche Ltd. - Key customers Exhibit 69: Lonza Group Ltd. - Vendor overview Exhibit 70: Lonza Group Ltd. - Business segments Exhibit 71: Lonza Group Ltd. - Organizational developments Exhibit 72: Lonza Group Ltd. - Geographic focus Exhibit 73: Lonza Group Ltd. - Segment focus Exhibit 74: Lonza Group Ltd. - Key offerings Exhibit 75: Lonza Group Ltd. - Key customers Exhibit 76: MaxCyte Inc. - Vendor overview Exhibit 77: MaxCyte Inc. - Business segments Exhibit 78: MaxCyte Inc. - Organizational developments Exhibit 79: MaxCyte Inc. - Key offerings Exhibit 80: MaxCyte Inc. - Key customers Exhibit 81: Merck KGaA - Vendor overview Exhibit 82: Merck KGaA - Business segments Exhibit 83: Merck KGaA - Organizational developments Exhibit 84: Merck KGaA - Geographic focus Exhibit 85: Merck KGaA - Segment focus Exhibit 86: Merck KGaA - Key offerings Exhibit 87: Merck KGaA - Key customers Exhibit 88: Polyplus-transfection SA - Vendor overview Exhibit 89: Polyplus-transfection SA - Product segments Exhibit 90: Polyplus-transfection SA - Organizational developments Exhibit 91: Polyplus-transfection SA - Key offerings Exhibit 92: Polyplus-transfection SA - Key customers Exhibit 93: Promega Corp. - Vendor overview Exhibit 94: Promega Corp. - Product segments Exhibit 95: Promega Corp. - Organizational developments Exhibit 96: Promega Corp. - Key offerings Exhibit 97: Promega Corp. - Key customers Exhibit 98: QIAGEN NV - Vendor overview Exhibit 99: QIAGEN NV - Business segments Exhibit 100: QIAGEN NV - Organizational developments Exhibit 101: QIAGEN NV - Geographic focus Exhibit 102: QIAGEN NV - Segment focus Exhibit 103: QIAGEN NV - Key offerings Exhibit 104: QIAGEN NV - Key customers Exhibit 105: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 106: Thermo Fisher Scientific Inc. - Business segments Exhibit 107: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 108: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 109: Thermo Fisher Scientific Inc. - Segment focus Exhibit 110: Thermo Fisher Scientific Inc. - Key offerings Exhibit 111: Thermo Fisher Scientific Inc. - Key customers Exhibit 112: Validation techniques employed for market sizing Exhibit 113: Definition of market positioning of vendors

Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Polyplus-transfection SA, Promega Corp., QIAGEN NV, and Thermo Fisher Scientific Inc.